(Q41703227)

English

Inhibition of protein synthesis enhances the lytic effects of tumor necrosis factor alpha and interferon gamma in cell lines derived from gynecological malignancies

scientific article published on January 1991

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Inhibition of protein synthesis enhances the lytic effects of tumor necrosis factor alpha and interferon gamma in cell lines derived from gynecological malignancies (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

author name string

L S Massad

1

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

D G Mutch

2

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

M S Kao

3

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

C B Powell

4

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

J L Collins

5

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1991

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

183-188

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Enhancement of cytotoxicity of cisplatin in vitro by recombinant human tumor necrosis factor and/or recombinant human interferon-alpha, -beta and -gamma

1 reference

https://api.crossref.org/works/10.1007%2FBF01756140

21 January 2018

Phase I study of a combination of recombinant tumor necrosis factor-alpha and recombinant interferon-gamma in cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FBF01756140

21 January 2018

Proliferative and antiproliferative effects of interferon-gamma and tumor necrosis factor-alpha on cell lines derived from cervical and ovarian malignancies

1 reference

https://api.crossref.org/works/10.1007%2FBF01756140

21 January 2018

Inhibition of tumor cell growth by interferon-gamma is mediated by two distinct mechanisms dependent upon oxygen tension: induction of tryptophan degradation and depletion of intracellular nicotinamide adenine dinucleotide

1 reference

https://pubmed.ncbi.nlm.nih.gov/1904315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1904315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant tumor necrosis factor: its effect and its synergism with interferon-gamma on a variety of normal and transformed human cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/1904315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon gamma induced oncolysis. An effect on head and neck squamous carcinoma cultures.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1904315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor receptors in HeLa cells and their regulation by interferon-gamma

1 reference

https://pubmed.ncbi.nlm.nih.gov/1904315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1904315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of a resistance mechanism in ovarian and cervical carcinoma cells prevents their lysis by gamma-interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/1904315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Common expression of a tumor necrosis factor resistance mechanism among gynecological malignancies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1904315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of proliferation of lines derived from human cervical carcinomas by cytotoxic drugs and by recombinant interferons

1 reference

https://pubmed.ncbi.nlm.nih.gov/1904315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of the efficacy of recombinant interferon gamma in relapsing ovarian adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/1904315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/1904315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1904315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic effects of interferon-gamma and tumor necrosis factor against proliferation of gynecologic tumor cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/1904315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Criteria for analyzing interactions between biologically active agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/1904315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of receptors for tumor necrosis factor-alpha by interferons is not a major mechanism for their synergistic cytotoxic response

1 reference

https://pubmed.ncbi.nlm.nih.gov/1904315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I trial of recombinant human tumor necrosis factor and interferon-gamma: effects of combination cytokine administration in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/1904315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1904315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic enhancement of the antitumor activity of recombinant human TNF-alpha by recombinant human IFN-gamma

1 reference

https://pubmed.ncbi.nlm.nih.gov/1904315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II clinical trial of high-dose recombinant human tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/1904315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I trial of recombinant gamma interferon in patients with cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1904315

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01756140

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Dimensions Publication ID

0 references

release_edk7pkpu7zawdikdulgfvilv6a

1 reference

https://api.fatcat.wiki/v0/release/edk7pkpu7zawdikdulgfvilv6a

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41703227&oldid=2204721446"